Vaccine

Papers
(The H4-Index of Vaccine is 59. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Editorial Board/Aims and Scope795
Referring to: Wilkinson K, Righolt CH, Elliott LJ, Fanella S, Mahmud SM. Pertussis vaccine effectiveness and duration of protection – a systematic review and meta-analysis. Vaccine. 2021 May 27;39(23)489
Inactivated whole influenza virus particle vaccines induce neutralizing antibodies with an increase in immunoglobulin gene subclones of B-lymphocytes in cynomolgus macaques387
RelCoVax®, a two antigen subunit protein vaccine candidate against SARS-CoV-2 induces strong immune responses in mice371
Pre-implementation evaluation for an HPV vaccine provider communication intervention among primary care clinics306
Economic evaluation of high-dose inactivated influenza vaccine in adults aged ≥65 years: A systematic literature review212
Adverse events following immunization: Findings from 2017/2018 measles vaccination campaign, Nigeria AEFI reporting in 2017/2018 measles vaccination campaign187
Vaccine value profile for Shigella181
List of abbreviations and acronyms used in Vaccine Value Profiles172
A non-toxic recombinant bivalent chimeric protein rETXm3CSAm4/TMD as a potential vaccine candidate against enterotoxemia and braxy165
A phase 3, multicenter, randomized, double-blind study to evaluate the interchangeability of V114, a 15-valent pneumococcal conjugate vaccine, and PCV13 with respect to safety, tolerability, and immun156
Cost of illness due to pertussis in adults ≥50 years of age in the United Kingdom146
COVID-19 vaccination in the Federal Bureau of Prisons, December 2020—April 2021141
Editorial Board/Aims and Scope140
Stamping the vaccine passport? Public support for lifting COVID-19 related restrictions for vaccinated citizens in France, Germany, and Sweden140
Exploring the ethics of using fictional stories for health education on social media to share information and emotions about the HPV vaccine: A cross-sectional study with interdisciplinary health expe138
Editorial Board/Aims and Scope138
Long-term predominance in childhood colonization of the multidrug-resistant lineage 6C/ST386 of Streptococcus pneumoniae after universal immunization with the 10-valent pneumococcal conjugate vaccine 128
Vaccination during febrile illness, what do we know? A systematic-narrative hybrid review of the literature and international recommendations122
Raising the case of hepatitis E: Report from the 2nd international HEV symposium119
Enhancing HPV vaccine uptake in girls and boys – A qualitative analysis of Canadian school-based vaccination programs117
Virtual reality for routine immunisations in needle phobic children with and without developmental disabilities: A pilot study116
Participant-reported neurological events following immunization in the Canadian National Vaccine Safety Network-COVID-19 vaccine (CANVAS-COVID) study109
Emerging global patterns of COVID-19 vaccine information fatigue in 23 countries in 2023109
MVA-BN vaccine effectiveness: A systematic review of real-world evidence in outbreak settings108
Changes in population genetic structure of serotype 19A Streptococcus pneumoniae after universal childhood use of the 10-valent pneumococcal conjugate vaccine in Brazil107
Meeting summary: Global vaccine and immunization research forum, 202397
A framework for monitoring RSV prevention product effectiveness in the United States94
Recombinant zoster vaccine and the risk of dementia89
Raman spectroscopy as a tool for detection of lung cancer and verification of vaccination effect – Correlation with biochemical data88
“They need to speak a language everyone can understand”: Accessibility of COVID-19 vaccine information for Canadian adults with intellectual and developmental disabilities85
Immunization and challenge trials in a murine model using different inactivated recombinant vaccines against H1N1 swine influenza virus circulating in Brazil85
Cost-effectiveness of anti-viral treatment for infants with RSV disease in the United Kingdom82
Navigating the future of vaccination strategies: Insights from the 17th annual vaccine congress81
Corrigendum to Assessment of the Bnt162b2 covid-19 vaccine immune response in Brazilian indigenous adolescents. Vaccine Volume 43, Part 1, 1 January 2025, 12649479
Knowledge, attitudes, and practices of healthcare providers regarding vaccinating children with cancer in Latin America and the Caribbean78
Moderate effectiveness of influenza vaccine in outpatient settings: A test-negative study in Beijing, China, 2023/24 season78
Streptococcus pneumoniae carriage, serotypes, genotypes, and antimicrobial resistance trends among children in Portugal, after introduction of PCV13 in National Immunization Program: A cross-sectional76
Humoral response superiority of the monovalent XBB.1.5 over the bivalent BA.1 and BA.5 mRNA COVID-19 vaccines74
Impact of the COVID-19 pandemic on routine childhood vaccination in 9 U.S. jurisdictions73
Editorial Board72
Influenza vaccine uptake among youth with sickle cell disease who are seen in clinic before and after the COVID-19 pandemic72
Immunogenicity of a 30-valent M protein mRNA group A Streptococcus vaccine71
Long-term impact of rotavirus vaccination on all-cause and rotavirus-specific gastroenteritis and strain distribution in Central Kenya: An 11-year interrupted time-series analysis71
Longevity of serologic responses following a single dose of typhoid conjugate vaccine among children living with HIV in Pakistan: A prospective cohort study70
Dynamics of multisystem inflammatory syndrome in children associated to COVID-19 in Chile: Epidemiologic trends during pandemic, before and after children vaccination70
Adjuvant-dependent impacts on vaccine-induced humoral responses and protection in preclinical models of nasal and genital colonization by pathogenic Neisseria70
Corrigendum to “Sustainability of measles, rubella, and congenital rubella syndrome (CRS) elimination in the United States, January 2022 – June 2024” [Vaccine 46C (2025) 126681]68
Corrigendum to “A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy i68
Closing the gap on vaccine uptake in developing countries: Is there a role for cash incentives?67
Real-world evidence of yellow Fever vaccination data-driven study65
Prolonged immune response to tick-borne Ehrlichia chaffeensis infection using a genetically modified live vaccine63
Reverse vaccinology: A strategy also used for identifying potential vaccine antigens in poultry62
Intervention-amenable factors associated with lack of HPV vaccination in Kenya: Results from a large national phone survey62
Modelling the impact and cost-effectiveness of upcoming Zika virus vaccines on congenital Zika syndrome62
Long-term antibody trajectories after PPSV23 in elderly: Results from a 4-year follow-up study62
Association between parental vaccine hesitancy and geographical coverage for childhood vaccination: A cross-sectional study61
Exploring the delivery of adult vaccination outside of primary care settings: A mixed methods scoping review61
Pseudovirus nanoparticles targeting the receptor binding HA1 domains of influenza viruses elicited high HA1-specific antibody responses and protected mice against mortality caused by influenza virus c59
Effectiveness of the ten- and thirteen-valent pneumococcal conjugate vaccines to prevent serotype 19A invasive pneumococcal disease in Quebec, Canada. A Canadian immunization research network (CIRN) s59
0.052042007446289